Hollings Renton, Director at ANAPTYSBIO, INC (ANAB), sold 6,030 shares at $23.97 ($145K) on 2025-06-18, disclosed to the SEC on 2025-06-20.
Scheduled sale ($145k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.97 | 3,015 | $72K | 50.0% |
| 2 | $23.97 | 3,015 | $72K | 50.0% |
| Total | $23.97 avg | 6,030 | $145K | 100% |
| Filing → |
| ANAB | SELL | 2024-12-03 | $250K | — | Filing → |
| ANAB | SELL | 2024-07-17 | $613K | — | Filing → |
| ANAB | SELL | 2024-06-18 | $45K | — | Filing → |